Magnesium Sulfate and Diphenylhydantoin Relax Canine Middle Cerebral Artery Contracted with the Thromboxane-A₂ Analogue U46619 by Different Mechanisms: Implications for the Management of Eclampsia

References

• Horn E H, Filshie M, Kerslake R W, Jaspan T, Worthington B S, Rubin P C. Widespread cerebral ischaemia treated with nimodipine in a patient with eclampsia. Br Med J 1990; 301: 794
   PubMed Web of Science ®Google Scholar
• Lewis L K, Hinshaw D B, Jr, Will A D, Nasso A N, Thompson J R. CT and angiographic correlation of severe neurological disease in toxemia of pregnancy. Neuroradiology 1988; 100: 131–40
   Google Scholar
• Pritchard J A, Pritchard S A. Standardized treatment of 154 consecutive cases of eclampsia. Am J Obstet Gynecol 1975; 123: 543–52
   PubMed Web of Science ®Google Scholar
• Dommisse J. Phenytoin sodium and magnesium sulphate in the management of eclampsia. Br J Obstet Gynaecol 1990; 97: 104–9
   PubMedGoogle Scholar
• Slater R M, Smith W D, Patrick J, et al. Phenytoin infusion in severe preeclampsia. Lancet 1987; 2: 1417–21
   Google Scholar
• Ryan G, Lange I R, Naugler M A. Clinical experience with phenytoin prophylaxis in severe preeclampsia. Am J Obstet Gynecol 1989; 161: 1297–304
   PubMed Web of Science ®Google Scholar
• Zaret G M. Possible treatment of preeclampsia with calcium channel blocking agents. Med Hypotheses 1983; 12: 303–19
   PubMedGoogle Scholar
• Belfort M A, Carpenter R J, Moise K J, Saade G R. The use of nimodipine in a patient with eclampsia: color doppler demonstration of retinal artery relaxation. Am J Obstet Gynecol 1993; 169: 204–6
   PubMedGoogle Scholar
• Belfort M A, Moise K J. The effect of magnesium sulfate on maternal brain blood flow in mild preeclampsia: a randomized placebo-controlled study. Am J Obstet Gynecol 1992; 167: 661–6
   PubMed Web of Science ®Google Scholar
• Belfort M A, Saade G R, Moise K J. The effect of magnesium sulfate on maternal retinal blood flow in preeclampsia: a randomized placebo-controlled study. Am J Obstet Gynecol 1992; 167: 1548–53
   PubMedGoogle Scholar
• Perales A J, Torregrossa G, Salom J B, Miranda F J, Alabadi J A, Monleon J, Alborch E. In vivo and in vitro effects of magnesium sulfate in the cerebrovascular bed of the goat. Am J Obstet Gynecol 1991; 165: 1534–8
   PubMedGoogle Scholar
• Iseri L T, French J H. Magnesium: nature's physiologic calcium blocker. Am Heart J 1984; 108: 188–94
   PubMed Web of Science ®Google Scholar
• Watson K V, Moldow C F, Ogburn P L, Jacob H S. Magnesium sulfate: rationale for its use in preeclampsia. Proc Natl Acad Sci USA 1986; 83: 1075–8
   PubMed Web of Science ®Google Scholar
• Pincus J H, Lee S H. Diphenylhydantoin and calcium. Arch Neurol 1973; 29: 239–44
   PubMedGoogle Scholar
• Fukuda A, Tabuse H, Diara N, Tanabe J, Eceda H, Kohama A. Effects of phenytoin on regional cerebral blood flow, electroencephalogram, and electrolyte contents in cerebral blood and cerebral cortex following total cerebral ischemia in dogs. Circulatory Shock 1983; 10: 341–50
   PubMedGoogle Scholar
• Gerthoffer W T, Shafer P G, Taylor S. Selectivity of phenytoin and dihydropyridine calcium channel blockers for relaxation of the basilar artery. J Cardiovasc Pharmacol 1987; 10: 9–15
   PubMedGoogle Scholar
• Furchgott R F, Zawadski J V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373–6
   PubMed Web of Science ®Google Scholar
• Vanhoutte P M. Could the absence or malfunction of vascular endothelium precipitate the occurrence of vasospasm. J Mol Cell Cardiol 1986; 18: 679–89
   PubMedGoogle Scholar
• Rappaport V J, Hirata G, Yap H K, Jordan S C. Antivascular endothelial cell antibodies in severe preeclampsia. Am J Obstet Gynecol 1990; 162: 138–46
   PubMed Web of Science ®Google Scholar
• Katusic Z S, Shepard J T, Vanhoutte P M. Vasopressin causes endothelium-dependent relaxations of the canine basilar artery. Circ Res 1984; 55: 575–9
   PubMed Web of Science ®Google Scholar
• Vanhoutte P M. Endothelium and control of vascular function. State of the art lecture. Hypertension 1989; 13: 658–67
   PubMed Web of Science ®Google Scholar
• Spokas E G, Folco G, Quilley J, Chandler P, McGiff J C. Endothelial mechanism in the vascular action of hydralazine. Hypertension 1983; 5(Suppl 1)107–11
   Google Scholar
• Godfraind T, Egleme C, Osachie I A. Role of endothelium in the contractile response of rat aorta to alpha-adrenoccptor agonists. Clin Sci 1987, Suppl 10: 65s–71s
   Google Scholar
• Mostaghim R, Maddox Y T, Ramwell P W. Endothelial potentiation of relaxation response to beta adrenoreceptor blocking agents. J Pharmacol Exp Ther 1986; 239: 797–801
   PubMedGoogle Scholar
• Ramsay R E, Hannond E J, Perchalski R J, Wilder B J. Brain uptake of phenytoin, phenobarbital, and diazepam. Arch Neurol 1979; 36: 535–9
   PubMedGoogle Scholar
• Winter M E, Tozer T N. Phenytoin. Applied pharmacokinetics-principles of therapeutic drug monitoring. 2nd ed., W E Evans, J J Schentag, W J Jusko. Applied Therapeutics, San Francisco 1986; 493–539
   Google Scholar
• Chesley L C. Parenteral magnesium sulfate and the distribution, plasma levels, and excretion of magnesium. Am J Obstet Gynecol 1979; 133: 1–7
   PubMedGoogle Scholar
• Sjogren A, Edvinsson L. Vasomotor effects of magnesium: A comparison with nifedipine and verapamil of in vitro reactivity in feline cerebral and peripheral arteries. Magnesium 1986; 5: 66–75
   PubMedGoogle Scholar
• Cotton D B, Gonik B, Dorman K R. Cardiovascular alterations in severe pregnancy-induced hypertension: acute effects of intravenous magnesium sulfate. Am J Obstet Gynecol 1984; 148: 162–5
   PubMed Web of Science ®Google Scholar